Evidence map›Paper›PMID 42163349›Full record

ArticleJournal of nanobiotechnology2026

Dephosphorylation-regulated MNAzyme-PER cascade as a programmable converter for multi-task molecular actuation.

Yaoyi Zhang, Yiqi Zhang, Jianbo Jiang, Dan Bai, Li Zhang, Li Wang, Xingping Hu, Jiu Pu, Yu He, Xiaole Han and 7 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yaoyi Zhang *Key Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Yiqi Zhang *Key Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Jianbo Jiang *Key Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Dan Bai *Key Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Li ZhangKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Li WangThe Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, PR China.
Xingping HuThe Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, PR China.
Jiu PuKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Yu HeKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Xiaole HanKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Weitao WangKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Na YinKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Xiaomei LinKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Xingyu LiuKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
Tingmei ChenKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China. tingmeichen@cqmu.edu.cn.
Yongcan GuoKey Laboratory of Luzhou, Department of Clinical Laboratory, Nanobiosensing and Microfluidic Point-of-Care Testing, The Affiliated Traditional Chinese Medicine Hospital Southwest Medical University, Luzhou, 646000, PR China. guoyongcan@swmu.edu.cn.
Guoming XieKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China. guomingxie@cqmu.edu.cn.

Funding

National Natural Science Foundation of China 82372351National Natural Science Foundation of China 82402696Natural Science Foundation of Chongqing CSTB2024NSCQ-MSX1223
6 · The paper itself

Abstract

Nucleic acid conformational regulation and enzymatic dynamic modulation play a pivotal role in creating collaborative amplification systems with programmable responses. However, the coordination of sophisticated molecular functions within synergistic cascade networks remains constrained by limited progress in leakage mitigation and modular functionality expansion. Here, we report a dephosphorylation-regulated MNAzyme-primer exchange reaction (PER)-based (Dp-PER) strategy, with its core mechanism centered on cyclic phosphate-locked conformation to suppress signal leakage. This design specifically incorporates upstream primer formulation and an enzyme-orchestrated cascade, seamlessly connecting upstream molecular network to PER circuit through dephosphorylation-induced conformational release. Within the sequential reaction mechanism, the transduction module exhibits intrinsic reactivity confinement and strategic activation in actuation of the amplification module distinct from traditional downstream primer. Importantly, the highly programmable MNAzyme sensing arm enables the Dp-PER to respond flexibly to diverse molecular cues. This capability underpins various tasks, including logical operations (YES, NOT, OR, AND, INHIBIT), multifunctional biosensing (nucleic acid, enzyme), and nanostructure cascading with tetrahedral DNA. The MNAzyme-PER enzymatic cascade is a scalable, compatible system that acts as a universal converter in hierarchical DNA networks. It provides a versatile foundation to transform molecular information into actionable outputs, demonstrating the potential of DNA nanotechnology in programmable biosensing and molecular computation.

Indexed as

Biosensing TechniquesDNADNA, CatalyticNucleic Acid Amplification TechniquesDNA NanostructuresNanostructuresNucleic Acid ConformationPhosphorylationDNADNA, CatalyticDephosphorylationLogical operationMNAzymeMultifunctional detectionPrimer exchange reactionTetrahedral DNA nanostructure

Identifiers

PMID42163349
PMCPMC13366803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.